Cargando…
Onychomadesis and palmoplantar keratoderma associated with talquetamab therapy for relapsed and refractory multiple myeloma
Autores principales: | Narayan, Neha, Williams, Benjamin, Lipe, Brea, De Benedetto, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731837/ https://www.ncbi.nlm.nih.gov/pubmed/36505036 http://dx.doi.org/10.1016/j.jdcr.2022.11.013 |
Ejemplares similares
-
Effects of teclistamab and talquetamab on soluble BCMA levels in patients with relapsed/refractory multiple myeloma
por: Girgis, Suzette, et al.
Publicado: (2022) -
Palmoplantar Keratoderma with Keratoconus
por: Gupta, Ved Prakash, et al.
Publicado: (2018) -
P892: ANALYSIS OF INFECTIONS AND PARAMETERS OF HUMORAL IMMUNITY IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH TALQUETAMAB (TAL) MONOTHERAPY IN MONUMENTAL-1
por: Rasche, Leo, et al.
Publicado: (2023) -
Palmoplantar keratoderma with dental abnormalities
por: Kaliyadan, Feroze, et al.
Publicado: (2014) -
Talquetamab: A promising immunotherapy for multiple myeloma
por: Tariq, Amna, et al.
Publicado: (2023)